CHELMSFORD, Mass. — Brooks Life Science Systems announced today the expansion of its sample preparation and bioprocessing laboratory services at its BioStorage® Technologies center of excellence biorepository in Indianapolis.

Brooks’ expanded sample bioprocessing capabilities in Indianapolis will include a full range of sample preparation services such as volumetric and normalized aliquoting, nucleic acid extraction, blood fractionation and PBMC isolation as well as cryopreservation services that will leverage existing best practices and protocols created by the BioProcessing Solutions Alliance with RUCDR® Infinite Biologics. The site expansion is a byproduct of customer needs and offers harmonized and validated services in Indianapolis around nucleic acid extraction and PBMC cryopreservation services that support life sciences discovery and development.

“With the expansion in key geographic regions, we are pleased to offer services that will facilitate our customer’s global clinical trials,” said Dr. Andrew Brooks, Chief Scientific Officer and Scientific and Co-Managing Director of the Bioprocessing Solutions Alliance. “Standardized methods, training and competency programs allow us to provide consistent, high-quality biomaterial preparations that can be used for phenotypic or functional analyses in support of both discovery and clinical applications,” said Brooks.

This announcement comes on the heels of Brooks Life Sciences’ plans to expand its state-of-the-art biorepository facility in Indianapolis. The expansion represented a 20 percent increase in footprint and a 55 percent increase in new freezers and features some of the latest innovations in sample management automation and cryogenic storage solutions. These expansions enable Brooks to provide redundancy critical to risk mitigation plans while meeting the growing needs for sample storage and lab services among life sciences customers.

“Our expanded analytical laboratory services, strategically located next to the Indianapolis International Airport and the FedEx Air Freight National Hub will allow for sample preparation and bioprocessing of time-sensitive samples such as PBMCs and other primary cells requiring isolation and cryopreservation,” said Martin Long, VP/General Manager, Brooks Life Science Systems.

BioStorage Technologies, a subsidiary of Brooks, has an ISO 9001:2015 biorepository and laboratory facility in Indianapolis and offers additional sample management solutions in Europe and Asia-Pacific.  The Bioprocessing Solutions Alliance enables Brooks to offer CAP and CLIA certified sample bioprocessing at its facility in New Jersey. All lab services sites in the US are accredited by the College of American Pathologists (CAP) and maintain US FDA 21 CFR Part 11 compliant technology systems, while adhering to local government regulations, GxP compliance as well as U.S. Department of Transportation and International Air Transport Association guidelines.

For more information, visit www.brooks.com/lifescience

About Brooks Life Science Systems
Brooks Life Science Systems, a division of Brooks Automation, is the leading worldwide provider of innovative and comprehensive sample lifecycle management solutions for the bioscience industry. These solutions include our automated storage systems, sample consumables and instruments, cell cryopreservation storage products, onsite and offsite temperature-controlled storage models, global sample preparation and analytical lab services and innovative informatics systems and technology services. Our team of sample management experts, deliver high quality, flexible sample management products, services and technology solutions that support hundreds of bioscience customers around the world, including the top 20 biopharmaceutical companies. Our industry-leading sample management solutions enable our customers to unlock sample intelligence and advance scientific research in order to deliver healthier and brighter tomorrows to individuals around the world.